Actinium Pharmaceuticals, Inc. financial data

Symbol
ATNM on NYSE
Industry
Pharmaceutical Preparations
Location
100 Park Ave., 23 Rd Floor, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Cactus Ventures, Inc. (to 3/29/2013)
Latest financial report
Q1 2024 - Apr 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1 K % -24.7%
Debt-to-equity 102 % +53.7%
Return On Equity -57 % -75.8%
Return On Assets -51.9 % -51.7%
Operating Margin -64.1 K % -1836%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.4 M shares +14.3%
Common Stock, Shares, Outstanding 29.4 M shares +14.3%
Entity Public Float 200 M USD +67.5%
Common Stock, Value, Issued 29 K USD +11.5%
Weighted Average Number of Shares Outstanding, Basic 27.9 M shares +8.52%
Weighted Average Number of Shares Outstanding, Diluted 27.9 M shares +8.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 81 K USD -92.1%
Research and Development Expense 37.5 M USD +40.7%
General and Administrative Expense 12.6 M USD -10.3%
Operating Income (Loss) -49.9 M USD -23.2%
Nonoperating Income (Expense) 3.48 M USD +118%
Net Income (Loss) Attributable to Parent -46.5 M USD -19.3%
Earnings Per Share, Basic -1.71 USD/shares -8.92%
Earnings Per Share, Diluted -1.71 USD/shares -8.92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.1 M USD -11.1%
Other Assets, Current 226 K USD +248%
Assets, Current 85.4 M USD -13.4%
Property, Plant and Equipment, Net 496 K USD -21.3%
Operating Lease, Right-of-Use Asset 2.14 M USD -15.9%
Assets 88.4 M USD -13.4%
Liabilities, Current 8.06 M USD +2.54%
Operating Lease, Liability, Noncurrent 1.41 M USD
Liabilities 44.5 M USD -0.72%
Retained Earnings (Accumulated Deficit) -346 M USD -15.5%
Stockholders' Equity Attributable to Parent 43.9 M USD -23.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 57.2 M USD -16.9%
Liabilities and Equity 88.4 M USD -13.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.37 M USD +51.1%
Net Cash Provided by (Used in) Financing Activities 14.8 M USD +1818%
Net Cash Provided by (Used in) Investing Activities -11 K USD +85.5%
Common Stock, Shares Authorized 1 B shares 0%
Common Stock, Shares, Issued 29.4 M shares +14.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.4 M USD -148%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 84.4 M USD -11.4%
Deferred Tax Assets, Valuation Allowance 90.6 M USD +19%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 1.95 M USD
Depreciation 207 K USD +36.2%
Payments to Acquire Property, Plant, and Equipment 11 K USD -85.5%
Lessee, Operating Lease, Liability, to be Paid 2.12 M USD
Operating Lease, Liability, Current 540 K USD +7.36%
Lessee, Operating Lease, Liability, to be Paid, Year Two 630 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 466 K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 165 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 643 K USD
Deferred Tax Assets, Operating Loss Carryforwards 41.7 M USD -5.73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 380 K USD
Operating Lease, Payments 153 K USD +2%
Additional Paid in Capital 390 M USD +9.27%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 89 K USD -84.2%
Share-based Payment Arrangement, Expense 6 K USD -62.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%